MedPath

Ertugliflozin pidolate

Generic Name
Ertugliflozin pidolate
Brand Names
Steglatro, Segluromet, Steglujan

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Merck Sharp & Dohme LLC
0006-5369
ORAL
2.5 mg in 1 1
9/12/2023
A-S Medication Solutions
50090-6183
ORAL
15 mg in 1 1
9/12/2023
Merck Sharp & Dohme LLC
0006-5364
ORAL
15 mg in 1 1
9/12/2023
A-S Medication Solutions
50090-6218
ORAL
2.5 mg in 1 1
10/13/2022
Merck Sharp & Dohme LLC
0006-5373
ORAL
2.5 mg in 1 1
9/12/2023
A-S Medication Solutions
50090-6182
ORAL
5 mg in 1 1
9/12/2023
Merck Sharp & Dohme LLC
0006-5370
ORAL
7.5 mg in 1 1
9/12/2023
Merck Sharp & Dohme LLC
0006-5374
ORAL
7.5 mg in 1 1
9/12/2023
A-S Medication Solutions
50090-6217
ORAL
2.5 mg in 1 1
10/13/2022
Merck Sharp & Dohme LLC
0006-5367
ORAL
5 mg in 1 1
10/20/2023

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath